{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:49:27Z","timestamp":1787060967197,"version":"build-2736575974"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2,15]]},"DOI":"10.1093\/cvr\/cvn230","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T20:24:41Z","timestamp":1218745481000},"page":"592-600","source":"Crossref","is-referenced-by-count":106,"title":["Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction"],"prefix":"10.1093","volume":"81","author":[{"given":"Justin F.X.","family":"Ainscough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Drinkhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Sedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Brooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Balmforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,8,14]]},"reference":[{"key":"key\n\t\t\t\t20170519083029_CVN230C1","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2003.11.064","article-title":"Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study","volume":"43","author":"Drazner","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170519083029_CVN230C2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/S0735-1097(98)00407-0","article-title":"Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death","volume":"32","author":"Haider","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170519083029_CVN230C3","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170519083029_CVN230C4","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170519083029_CVN230C5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","article-title":"Prognostic implications of left ventricular hypertrophy","volume":"141","author":"Vakili","year":"2001","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170519083029_CVN230C6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/01.RES.0000020201.44772.67","article-title":"Cardiomyocyte cell cycle regulation","volume":"90","author":"Pasumarthi","year":"2002","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170519083029_CVN230C7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cardiores.2005.03.010","article-title":"Moderate vs high exercise intensity: differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial function","volume":"67","author":"Kemi","year":"2005","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170519083029_CVN230C8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI24144","article-title":"Toward transcriptional therapies for the failing heart: chemical screens to modulate genes","volume":"115","author":"McKinsey","year":"2005","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170519083029_CVN230C9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2006.10.001","article-title":"Type 1 angiotensin receptor pharmacology: signaling beyond G proteins","volume":"113","author":"Oro","year":"2007","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t20170519083029_CVN230C10","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/HJH.0b013e3282257145","article-title":"Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study","volume":"25","author":"Barrios","year":"2007","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170519083029_CVN230C11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.CIR.0000083724.28630.C3","article-title":"Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study","volume":"108","author":"Okin","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170519083029_CVN230C12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ncb1137","article-title":"Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II","volume":"6","author":"Zou","year":"2004","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20170519083029_CVN230C13","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1073\/pnas.94.12.6391","article-title":"Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block","volume":"94","author":"Hein","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170519083029_CVN230C14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170519083029_CVN230C15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.RES.0000240147.49390.61","article-title":"An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy","volume":"99","author":"Zhai","year":"2006","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170519083029_CVN230C16","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1172\/JCI25330","article-title":"Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q\/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice","volume":"115","author":"Zhai","year":"2005","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170519083029_CVN230C17","first-page":"55","article-title":"Production of YAC transgenic mice by pronuclear injection","volume":"181","author":"Ainscough","year":"2001","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20170519083029_CVN230C18","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.theriogenology.2007.03.008","article-title":"Human menopausal and pregnant mare serum gonadotrophins in murine superovulation regimens for transgenic applications","volume":"67","author":"Brooke","year":"2007","journal-title":"Theriogenology"},{"key":"key\n\t\t\t\t20170519083029_CVN230C19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/6165","article-title":"Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice","volume":"17","author":"Redfern","year":"1999","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t20170519083029_CVN230C20","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0925-4773(99)00289-0","article-title":"Appropriate expression of the mouse H19 gene utilises three or more distinct enhancer regions spread over more than 130 kb","volume":"91","author":"Ainscough","year":"2000","journal-title":"Mech Dev"},{"key":"key\n\t\t\t\t20170519083029_CVN230C21","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1242\/dev.127.18.3923","article-title":"A skeletal muscle-specific mouse Igf2 repressor lies 40 kb downstream of the gene","volume":"127","author":"Ainscough","year":"2000","journal-title":"Development"},{"key":"key\n\t\t\t\t20170519083029_CVN230C22","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1242\/dev.124.18.3621","article-title":"Imprinting of Igf2 and H19 from a 130 kb YAC transgene","volume":"124","author":"Ainscough","year":"1997","journal-title":"Development"},{"key":"key\n\t\t\t\t20170519083029_CVN230C23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0898-6568(01)00135-8","article-title":"The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1\/2 activation is independent of angiotensin AT(1A) receptor internalisation","volume":"13","author":"Turner","year":"2001","journal-title":"Cell Signal"},{"key":"key\n\t\t\t\t20170519083029_CVN230C24","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1074\/jbc.272.7.4245","article-title":"The conformational change responsible for AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII","volume":"272","author":"Balmforth","year":"1997","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170519083029_CVN230C25","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1073\/pnas.110142297","article-title":"Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay","volume":"97","author":"Parnot","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170519083029_CVN230C26","doi-asserted-by":"crossref","first-page":"23107","DOI":"10.1074\/jbc.C200201200","article-title":"Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N- and C-terminal residues of angiotensin II during AT1 receptor activation","volume":"277","author":"Le","year":"2002","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170519083029_CVN230C27","doi-asserted-by":"crossref","first-page":"16435","DOI":"10.1021\/bi961593m","article-title":"The active state of the AT1 angiotensin receptor is generated by angiotensin II induction","volume":"35","author":"Noda","year":"1996","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170519083029_CVN230C28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bcp.2005.11.011","article-title":"Conformational induction is the key process for activation of the AT1 receptor","volume":"71","author":"Ellis","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170519083029_CVN230C29","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.102673599","article-title":"Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes","volume":"99","author":"Beggah","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170519083029_CVN230C30","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"Embo J"},{"key":"key\n\t\t\t\t20170519083029_CVN230C31","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI28764","article-title":"Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice","volume":"117","author":"Billet","year":"2007","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170519083029_CVN230C32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s001090100246","article-title":"Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy","volume":"79","author":"Hoffmann","year":"2001","journal-title":"J Mol Med"},{"key":"key\n\t\t\t\t20170519083029_CVN230C33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(97)00161-1","article-title":"Cardiac angiotensin II receptors: studies on functional coupling in Sprague\u2013Dawley rats and TGR(alphaMHC-hAT1) transgenic rats","volume":"330","author":"Rosenkranz","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170519083029_CVN230C34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvn020","article-title":"Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization","volume":"78","author":"Rivard","year":"2008","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170519083029_CVN230C35","doi-asserted-by":"crossref","first-page":"24613","DOI":"10.1016\/S0021-9258(18)54273-3","article-title":"Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice","volume":"266","author":"Subramaniam","year":"1991","journal-title":"J Biol Chem"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/81\/3\/592\/17236516\/cvn230.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T21:14:42Z","timestamp":1631654082000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-lookup\/doi\/10.1093\/cvr\/cvn230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,14]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,8,14]]},"published-print":{"date-parts":[[2009,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvn230","relation":{},"ISSN":["1755-3245","0008-6363"],"issn-type":[{"value":"1755-3245","type":"electronic"},{"value":"0008-6363","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8,14]]}}}